Oura is rolling out two new women’s health tools on May 6: Menopause Insights, which uses a clinical questionnaire to gauge symptoms and quality-of-life impact, and Hormonal Birth Control, linking contraceptive methods to biometric data to show effects on sleep, temperature, and cycles.

The rollout also includes a U.S. partnership with Twentyeight Health to expand care delivery—same-day virtual appointments, prescriptions, and ongoing contraceptive counseling, with cycle and sleep data feeding into personalized care.

After completing assessments, users receive a personalized dashboard that shows overall impact and contributing factors, with options to save results or share them with healthcare providers.

The author reports six months with the Oura Ring 4 Ceramic, praising its durability and pristine ceramic finish despite heavy daily wear.

The features are positioned as differentiators that sustain Oura’s premium status and value, even with a higher price and ongoing subscription.

Market context notes competition from Ultrahuman and RingConn, but Oura’s leadership and ecosystem innovation keep it hard to beat at present.

The information comes from Oura’s official announcement and a Yugatech article, with explicit notes on rollout timing and device compatibility.

Battery life remains strong, lasting at least five days per charge, with a battery-low alert when remaining time drops below 24 hours.

Global rollout of the update begins May 6, 2026, initially for Oura Ring Gen3 and Ring 4 Members, with a special emphasis on Series 3 and 4 as compatible devices.

The update is described as a first-of-its-kind experience inside the Oura app, highlighting a broader rollout starting May 6, 2026.

Users can track changes over time against the ring’s biometric data, export data, and share with healthcare providers to inform care decisions.

Oura is partnering with Maven and Progyny to weave ring-derived insights into clinical workflows and care plans.